Compare with FORTIS HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs FORTIS HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS FORTIS HEALTHCARE KRSNAA DIAGNOSTICS/
FORTIS HEALTHCARE
 
P/E (TTM) x - 33.7 - View Chart
P/BV x 9.5 3.5 275.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   FORTIS HEALTHCARE
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
FORTIS HEALTHCARE
Mar-21
KRSNAA DIAGNOSTICS/
FORTIS HEALTHCARE
5-Yr Chart
Click to enlarge
High RsNA217 0.0%   
Low RsNA113 0.0%   
Sales per share (Unadj.) Rs998.853.4 1,871.1%  
Earnings per share (Unadj.) Rs284.5-1.4 -20,707.1%  
Cash flow per share (Unadj.) Rs342.12.5 13,820.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.581.0 438.6%  
Shares outstanding (eoy) m6.50754.96 0.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x03.1 0.0%   
Avg P/E ratio x0-120.0 0.0%  
P/CF ratio (eoy) x066.6 0.0%  
Price / Book Value ratio x02.0 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m0124,493 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2968,490 3.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,49240,301 16.1%  
Other income Rs m122466 26.3%   
Total revenues Rs m6,61540,767 16.2%   
Gross profit Rs m3,4664,057 85.4%  
Depreciation Rs m3742,906 12.9%   
Interest Rs m2591,659 15.6%   
Profit before tax Rs m2,955-43 -6,930.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105995 111.1%   
Profit after tax Rs m1,849-1,037 -178.3%  
Gross profit margin %53.410.1 530.4%  
Effective tax rate %37.4-2,333.2 -1.6%   
Net profit margin %28.5-2.6 -1,106.7%  
BALANCE SHEET DATA
Current assets Rs m2,48110,368 23.9%   
Current liabilities Rs m1,83812,330 14.9%   
Net working cap to sales %9.9-4.9 -203.5%  
Current ratio x1.40.8 160.6%  
Inventory Days Days2571 35.0%  
Debtors Days Days41353 11.5%  
Net fixed assets Rs m3,56497,477 3.7%   
Share capital Rs m2,4897,550 33.0%   
"Free" reserves Rs m-17853,629 -0.3%   
Net worth Rs m2,31061,179 3.8%   
Long term debt Rs m1,6809,677 17.4%   
Total assets Rs m6,045107,845 5.6%  
Interest coverage x12.41.0 1,271.7%   
Debt to equity ratio x0.70.2 459.6%  
Sales to assets ratio x1.10.4 287.4%   
Return on assets %34.90.6 6,052.4%  
Return on equity %80.0-1.7 -4,720.8%  
Return on capital %80.52.3 3,531.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m021 0.0%   
Fx outflow Rs m011 0.0%   
Net fx Rs m010 0.0%   
CASH FLOW
From Operations Rs m1,0264,855 21.1%  
From Investments Rs m-611-1,351 45.3%  
From Financial Activity Rs m308-1,429 -21.6%  
Net Cashflow Rs m7232,120 34.1%  

Share Holding

Indian Promoters % 27.4 0.0 -  
Foreign collaborators % 0.0 31.2 -  
Indian inst/Mut Fund % 34.6 45.8 75.6%  
FIIs % 4.4 30.1 14.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 68.8 105.5%  
Shareholders   75,065 154,572 48.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    METROPOLIS HEALTHCARE    DR. LAL PATHLABS    KIMS    



Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

FORTIS HEALTHCARE 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of FORTIS HEALTHCARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of FORTIS HEALTHCARE. Also includes updates on the valuation of FORTIS HEALTHCARE.

FORTIS HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 321.3% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, FORTIS HEALTHCARE has posted a net profit of Rs 4 bn (up 321.3% YoY). Sales on the other hand came in at Rs 14 bn (up 132.7% YoY). Read on for a complete analysis of FORTIS HEALTHCARE's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 20, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 5-YR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS